Different distributions of hepatitis C virus genotypes among HIV-infected patients with acute and chronic hepatitis C according to interleukin-28B genotype

HIV Medicine

Volumn 12, Issue 8, 2011, Pages 487-493

  Neukam, K ^a   Nattermann, J ^b   Rallon N ^c   Rivero, A ^d   Caruz, A ^e   Macias J ^a   Vogel, M ^b   Benito, J M ^c   Camacho, Á ^d   Mira, J A ^a   Schwarze Zander, C ^b   Barreiro, P ^c   Martinez A ^d   Rockstroh, J K ^b   Soriano, V ^c   Pineda, Juan Antonio ^a  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^b UNIVERSITY OF BONN   (Germany)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^d HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^e UNIVERSITY OF JAÉN   (Spain)

Author keywords

Acute hepatitis C; Chronic hepatitis C; Genotype distribution; HIV; Interleukin 28B

Indexed keywords

INTERLEUKIN 28B;

ACUTE HEPATITIS; ADULT; ARTICLE; CHRONIC HEPATITIS; CHRONICITY; FEMALE; GENOTYPE; GERMANY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPAIN; VIRAL GENETICS;

ADULT; COINFECTION; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; INTERLEUKINS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 80051577238     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2011.00912.x     Document Type: Article

References (23)

1. Ge D, Fellay J, Thompson AJ et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009; 461: 399-401.
2. Tanaka Y, Nishida N, Sugiyama M et al. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 2009; 41: 1105-1109.
3. Suppiah V, Moldovan M, Ahlenstiel G et al. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet 2009; 41: 1100-1104.
4. McCarthy JJ, Li JH, Thompson A et al. Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin. Gastroenterology 2010; 138: 2307-2314.
5. Rauch A, Kutalik Z, Descombes P et al. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure - a genome-wide association study. Gastroenterology 2010; 138: 1338-1345.
6. Thomas DL, Thio CL, Martin MP et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009; 461: 798-801.
7. Pineda JA, Caruz A, Rivero A et al. Variation in interleukin 28B gene predicts response to pegylated interferon plus ribavirin in human immunodeficiency virus/hepatitis C virus-coinfected patients. Clin Infect Dis 2010; 51: 788-795.
8. Rallon N, Naggie S, Benito JM et al. Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus co-infected patients. AIDS 2010; 24: F23-F29.
9. Nattermann J, Vogel M, Baumgarten A et al. Genetic variation in IL28B and treatment-induced clearance of hepatitis C virus in HCV/HIV co-infected patients. 17th Conference on Retroviruses and Opportunistic Infections. San Francisco, CA, February 2010 [Abstract 164].
10. Montes-Cano M, García-Lozano JR, Abad-Molina C et al. IL28B genetic variants and hepatitis virus infection by different viral genotypes. Hepatology 2010; 52: 33-37.
11. Vogel M, Nattermann J, Baumgarten A et al. Pegylated interferon-α or the treatment of sexually transmitted acute hepatitis C in HIV-infected individuals. Antiviral Ther 2006; 11: 1097-1101.
12. Nischalke HD, Vogel M, Mauss S et al. The cytotoxic lymphocyte antigen 4 polymorphisms affect response to hepatitis C virus-specific therapy in HIV (+) patients with acute and chronic hepatitis C virus co-infection. AIDS 2010; 24: 2001-2007.
13. Thomas DL, Seeff LB. Natural history of hepatitis C. Clin Liver Dis 2005; 9: 383-398.
14. Soriano V, Vispo E, Labarga P, Medrano J, Barreiro P. Viral hepatitis and HIV co-infection. Antiviral Res 2010; 85: 303-315.
15. Tillmann HL, Thompson AJ, Patel K et al. A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice. Gastroenterology 2010; 139: 1586-1592.
16. Soriano V, Mocroft A, Rockstroh J et al. Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe. J Infect Dis 2008; 198: 1337-1344.
17. Urban TJ, Thompson AJ, Bradrick SS et al. IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C. Hepatology 2010; 52: 1888-1896.
18. Lindh M, Lagging M, Norkrans G, Hellstrand K. A model explaining the correlations between IL28B-related genotypes, hepatitis C virus genotypes, and viral RNA levels. Gastroenterology 2010; 139: 1794-1796.
19. Sulkowski MS, Benhamou Y. Therapeutic issues in HIV/HCV-coinfected patients. J Viral Hepat 2007; 14: 371-386.
20. Zein NN. Clinical significance of hepatitis C genotypes. Clin Microbiol Rev 2000; 13: 223-235.
21. O'Brien T. Interferon alfa, interferon λ and hepatitis C. Nat Genet 2009; 41: 1048-1050.
22. Browne R, Asboe D, Gilleece Y et al. Increased numbers of acute hepatitis C infections in HIV positive homosexual men: is sexual transmission feeding the increase? Sex Transm Infect 2004; 80: 326-327.
23. Danta M, Dusheiko GM. Acute HCV in HIV-positive individuals - a review. Curr Pharm Des 2008; 14: 1690-1697.